Ashwin Balagopal
Physician · Johns Hopkins School of Medicine
Credentials: · · · ·
History
- 2000–2003
Internal Medicine
Research
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C
Gastroenterology · 2008 · First of 11 authors · 225 citations
IL28B and the control of hepatitis C virus infection
Review · Gastroenterology · 2010 · First of 3 authors · Corresponding · 189 citations
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study
Annals of Internal Medicine · 2013 · 151 citations
- CT
18 papers
- MS
15 papers
11 papers
9 papers
8 papers
- AC
7 papers
- DA
6 papers
- JB
6 papers · 1 as a fellow
Grants
- 2025–2030
Hepatitis B and HIV Cure Consortium (BICC)
National Institute of Allergy and Infectious Diseases · U19
Project lead · $1.5M · Johns Hopkins University
- 2024–2029
HBV cccDNA Transcriptional Silencing with and Without HIV
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.4M · Johns Hopkins University
- 2016–2027
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
National Institute of Allergy and Infectious Diseases · R01
PI · $8.5M · Triad National Security, Llc
- 2018–2025
Mechanisms of HBV cccDNA Transcriptional Regulation in Persons with and Without HIV
National Institute of Allergy and Infectious Diseases · R56
Contact PI · $811K · Johns Hopkins University
Clinical trials
- 2020–2022
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)
Principal investigator · Completed · Phase 2
Ridgeback Biotherapeutics, LP